Tech Company Financing Transactions
Goldenrod Therapeutics Funding Round
Goldenrod Therapeutics closed a $6.5 million Seed funding round on 6/8/2026. Investors included Ataxia Ventures, Fannin and private investors.
Transaction Overview
Company Name
Announced On
6/8/2026
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Seed
Investors
Ataxia Ventures (Lead Investor)
Fannin (Lead Investor)
Proceeds Purpose
The company intends to use the funds to extend its manufacturing, formulation optimization and IND-enabling studies, along with funding a Phase I study in its beachhead therapeutic indication in Friedreich's Ataxia (FA), a rare and progressive neurodegenerative disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3900 Essex Ln 575
Houston, TX 77027
USA
Houston, TX 77027
USA
Phone
Website
Email Address
Overview
Goldenrod Therapeutics is a biotechnology company developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological disorders. The company focuses on overcoming historical tolerability limitations of earlier PDE4 inhibitors while achieving robust central nervous system exposure. Through disciplined translational development, Goldenrod advances its lead program toward clinical evaluation with the goal of delivering differentiated therapies for patients with significant unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dev Chatterjee
Chief Financial Officer
Mark Worscheh
President
Atul Varadhachary
Vice President
Ross Clary
VP - R & D
Brian Wipke
Browse more venture capital transactions:
Prev: 6/8/2026: Blnk venture capital transaction
Next: 6/8/2026: InfoHawk venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs